Meeting
2019 ASCO Quality Care Symposium
Efficacy of systemic treatment for metastatic renal cell carcinoma (mRCC) guided by comprehensive genomic profiling (CGP).
Authors
Paulo Gustavo Bergerot
City of Hope Comprehensive Cancer Center, Duarte, CA
Paulo Gustavo Bergerot, Cristiane Decat Bergerot, Nazli Dizman, Nicholas Salgia, Joann Hsu, Sumanta K. Pal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities
Sub Track
Team-Based Approaches to Care Delivery
Citation
J Clin Oncol 37, 2019 (suppl 27; abstr 63)
DOI
10.1200/JCO.2019.37.27_suppl.63
Abstract #
63
Poster Bd #
E10
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
PBRM1 mutation and immunotherapy efficacy: A comprehensive genomic profiling (CGP) assessment.
First Author: Gennady Bratslavsky
Poster
2018 Genitourinary Cancers Symposium
Genomic alterations to refine prognostication of patients with metastatic renal cell carcinoma.
First Author: Dominick Bosse
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic alterations in metastatic renal cell carcinoma (mRCC): Impact on survival and clinical outcomes.
First Author: Jennifer King
Poster
2022 ASCO Annual Meeting
Comprehensive genomic profiling (CGP) of chromophobe renal cell carcinoma (chrRCC) compared with non-chromophobe RCC (nonchrRCC): Impact of FLCN genomic alteration (GA) status.
First Author: Gennady Bratslavsky